Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-25 @ 8:54 PM
Study NCT ID:
NCT05335356
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2022-04-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis
Sponsor:
Biocon Biologics UK Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-15
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-13
First Submit QC Date:
None
Study First Post Date:
2022-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-26
Results First Submit QC Date:
None
Results First Post Date:
2025-09-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-09-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-08-26
Last Update Post Date:
2025-09-12
Last Update Post Date Type:
ESTIMATED